These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19825097)

  • 21. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports].
    Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ
    Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scleral changes due to mitomycin C after pterygium excision: a report of two cases.
    Saifuddin S; el Zawawi A
    Indian J Ophthalmol; 1995 Jun; 43(2):75-6. PubMed ID: 8818315
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combination chemotherapy of mitomycin C and cytosine arabinoside in superficial bladder tumors. 1. Evaluation of intravesical infusion therapy].
    Ikeuchi T; Onodera Y; Kai Y
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2145-51. PubMed ID: 6414383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urethral slough: a rare and previously unreported complication of intravesical mitomycin.
    Brady JD; Assimos DG; Jordan GH
    J Urol; 2000 Oct; 164(4):1305. PubMed ID: 10992392
    [No Abstract]   [Full Text] [Related]  

  • 25. [Intravesical instillation in the treatment of superficial tumors of the bladder].
    Chopin DK
    Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incrusted cystitis after intravesical mitomycin C treatment.
    Llopis M; Moreno J; Botella R; Algado M
    Acta Urol Belg; 1993 Sep; 61(3):21-3. PubMed ID: 8256682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.
    Solsona E; Iborra I; Ricós JV; Monrós JL; Casanova J; Dumont R
    J Urol; 1999 Apr; 161(4):1120-3. PubMed ID: 10081851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed-type sensitivity reaction to mitomycin.
    Giorgini S; Martinelli C; Sertoli A
    Contact Dermatitis; 1991 May; 24(5):378-9. PubMed ID: 1832622
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemolytic uremic syndrome--a serious complication of mitomycin treatment].
    Arola O; Aho H; Asola M; Kauppila M; Nikkanen V; Voipio-Pulkki LM
    Duodecim; 1997; 113(19):1923-9. PubMed ID: 10892085
    [No Abstract]   [Full Text] [Related]  

  • 30. [Periodic prophylactic bladder instillation (PPI) of mitomycin C].
    Mishina T; Watanabe H; Fujiwara T; Kobayashi T; Maegawa M; Nakao M; Nakagawa S
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):365-71. PubMed ID: 6820896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitomycin-induced interstitial pneumonitis in a patient with BRCA2 associated metastatic pancreatic carcinoma.
    Saif MW; Dai T
    JOP; 2010 May; 11(3):277-9. PubMed ID: 20442529
    [No Abstract]   [Full Text] [Related]  

  • 32. Bacillus Calmette-Guérin versus mitomycin C for the treatment of intermediate-risk non-muscle-invasive bladder cancer: the debate continues.
    Sylvester RJ
    Eur Urol; 2009 Aug; 56(2):266-8; discussion 268-9. PubMed ID: 19427110
    [No Abstract]   [Full Text] [Related]  

  • 33. Unexpected increase in the bone marrow toxicity of mitomycin C (MMC).
    Yoshimoto M; Saito M; Tada T; Kasumi KT
    Br J Cancer; 2001 Mar; 84(5):736-7. PubMed ID: 11237399
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mitomycin C caused contact allergy].
    Wahlberg JE; Lindelöf B
    Lakartidningen; 1993 Jan; 90(3):158. PubMed ID: 8429749
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study.
    Di Stasi SM; Giannantoni A; Stephen RL; Capelli G; Navarra P; Massoud R; Vespasiani G
    J Urol; 2003 Sep; 170(3):777-82. PubMed ID: 12913696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparative study of BCG and mitomycin C in superficial carcinomas of the bladder].
    Iavarone C; Minocchi L; Arecchi S; Nicolucci D; Porcelli C; D'orazi V; Greco L; Stio F; Martino G; Messinetti S
    G Chir; 1996 May; 17(5):289-91. PubMed ID: 8755233
    [No Abstract]   [Full Text] [Related]  

  • 37. Scrotal ulcer after intraperitoneal hyperthermic chemotherapy.
    Akhavan A; Yin M; Benoit R
    Urology; 2007 Apr; 69(4):778.e9-10. PubMed ID: 17445676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microcapsule chemoembolization therapy: a new approach to bladder cancer.
    Kato T
    Prog Clin Biol Res; 1984; 162B():359-63. PubMed ID: 6209723
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anti-tumor effect of intravesical instillation of mitomycin C combined with cytosine arabinoside].
    Matsuda M; Matsumiya K; Tada Y; Nakano E; Fujioka H; Osafune M; Takaha M; Sonoda T
    Hinyokika Kiyo; 1984 Sep; 30(9):1145-51. PubMed ID: 6441472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A very rare side effect of mitomycin-C: psoriasiform drug eruption.
    Cicek D; Cobanoglu B; Inci R; Dertlioglu SB; Kokcam I; Elkiran T
    Int J Dermatol; 2013 Dec; 52(12):1572-4. PubMed ID: 24261729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.